Results
|
|
1.
|
|
|
|
2.
|
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). MedStar authors:
Year: 2024
Citation: - Journal of Clinical Oncology. 42(12):1344-1349, 2024 Apr 20.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Geyer CE Jr, Blum JL, Yothers G, Asmar L, Flynn PJ, Robert NJ, Hopkins JO, O'Shaughnessy JA, Rastogi P, Puhalla SL, Hilton CJ, Dang CT, Gomez HL, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Colangelo LH, Swain SM, Mamounas EP, Wolmark N
|
|
|
3.
|
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. [Review] MedStar authors:
Year: 2021
Citation: - Cancers. 13(7), 2021 Mar 29.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Bottiglieri S, Carballido E, Cueto AD, Hicks JK, Imanirad I, Levine R, Nelson RS, Parker AS, Seligson ND, Swain SM, Tillman EM
|
|
|
4.
|
|
|
|
5.
|
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. MedStar authors:
Year: 2022
Citation: - Cancers. 14(11), 2022 May 24.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Colomer R, Dadswell K, Dang C, de Haas SL, de la Cruz-Merino L, Delaloge S, Eiger D, Ewer MS, Ferrero JM, Restuccia E, Sarkar S, Swain SM, Verrill M, Werner TL
|
|
|
6.
|
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. MedStar authors:
Year: 2021
Citation: - Cancers. 13(9), 2021 May 08.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Aapro M, Abdel Aziz H, Abdel Karim K, Abulkhair O, Al-Sukhun S, Anderson BO, Aref AT, Arun B, Azim HA, Bahie Eldin N, Bakkach J, Balch CM, Conte P, El Saghir NS, El-Shinawi M, El-Zawahry HM, Elghazaly H, Elghazawy H, ElMahdy M, Foheidi M, Frolova M, Ghosn M, Giuliano AE, Gligorov J, Guarneri V, Gulluoglu BM, Kandil A, Leung JWT, Orecchia R, Paltuev RM, Penault-Llorca F, Perez EA, Poortmans P, Rugo HS, Sabry M, Shehata MA, Swain SM, Yang W, Yip CH
|
|
|
7.
|
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. MedStar authors:
Year: 2022
Citation: - Cancers. 14(20), 2022 Oct 15.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Cortazar P, Cortes J, Dang C, du Toit Y, Gianni L, Heinzmann D, Hurvitz SA, Jackisch C, Knott A, Macharia H, Schneeweiss A, Slamon D, Song C, Swain SM, Valagussa P
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+ operable breast cancer: NSABP protocol B-41. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(18_suppl):LBA506, 2012 Jun 20
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky A, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE, Kuebler JP, Mamounas EP, Margolese RG, Paik S, Rastogi P, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
12.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. MedStar authors:
Year: 2020
Citation: - Lancet Oncology. 21(4):519-530, 2020 Apr.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Benyunes MC, Ciruelos E, Clark E, CLEOPATRA study group, Cortes J, Im SA, Im YH, Kim SB, Knott A, Loi S, Miles D, Monturus E, Restuccia E, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
13.
|
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer. MedStar authors:
Year: 2022
Citation: - European Journal of Cancer. 178:70-81, 2022 Oct 07.
Medline publication type:
All authors: - Aguila C, Dang CT, Gianni L, Heeson S, Kuemmel S, Liu H, Loibl S, Macharia H, O'Shaughnessy J, Restuccia E, Schneeweiss A, Swain SM, Tan AR, Yang K
|
|
|
14.
|
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC). MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(26_suppl):61, 2014 Sep 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bogaerts J, Bonnefoi HR, Cameron DA, Cortazar P, Costantino JP, Eidtmann H, Gerber B, Geyer CE, Gianni L, Loibl S, Mehta K, Rastogi P, Sridhara R, Swain SM, Untch M, Valagussa P, Von Minckwitz G, Wolmark N, Zhang L
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
Year: 2023
Citation: - Breast Cancer Research & Treatment. 2023 Mar 22
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Rastogi P, Tang G, Hassan S, Geyer CE Jr, Azar CA, Magrinat GC, Suga JM, Bear HD, Baez-Diaz L, Sarwar S, Boileau JF, Brufsky AM, Shibata HR, Bandos H, Paik S, Yothers G, Swain SM, Mamounas EP, Wolmark N
|
|
|
18.
|
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . MedStar authors:
Year: 2023
Citation: - Annals of Oncology. 2023 Dec 08
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N
|
|
|
19.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
20.
|
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx R Digital Spatial Profiler. MedStar authors:
- Schlam, Ilana
- Swain, Sandra M
Year: 2021
Citation: - Cancers. 13(17), 2021 Sep 04.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology and Oncology
- MedStar Health
Medline publication type:
All authors: - Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, On Behalf Of The GeoMx Breast Cancer Consortium, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin O, Sato H, Schlam I, Sorlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE
|
|
|
21.
|
|
|
|
22.
|
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J
|
|
|
23.
|
|
|
|
24.
|
Ten-year Update: NRG Oncology/NSABP B-42 Randomized Trial: Extended Letrozole Therapy in Early-stage Breast Cancer. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2023
Citation: - Journal of the National Cancer Institute. 2023 May 15
Institution:
- Associate Dean for Research Development
- MedStar Franklin Square Medical Center
- MedStar Health
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Rastogi P, Soori GS, Swain SM, Wade JL, Walshe JM, Wolmark N
|
|
|
25.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2202364, 2023 Feb 23
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
26.
|
|
|
|
27.
|
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Gallagher, Christopher
- Hofmeyer, Mark
- Lynce, Filipa
- Srichai, Monvadi B
- Swain, Sandra M
Year: 2021
Citation: - Breast Cancer Research & Treatment. 2021 Jan 05
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Asch F, Barac A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Khoury K, Lynce F, Nunes R, Pohlmann PR, Smith KL, Srichai MB, Swain SM, Tan M, Warren R, Yu AF
|
